Abiopharma

🔍 Singh Jesse G (Director)

Company: James Hardie Industries plc (JHX)

Report Date: 2026-08-21

Detailed Transactions and Holdings:

• Sold 103,400 shares of Ordinary shares at $30.22 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 118,057 shares of Ordinary shares at $30.34 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 381,683.00 | transaction_form_type: 4 | Footnotes: F3, F4
• Acquired 265,000 shares of Ordinary shares at $11.23 per share (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 382,028.00 | transaction_form_type: 4
• Sold 265,000 shares of Ordinary shares at $30.19 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 117,028.00 | transaction_form_type: 4 | Footnotes: F5
• Sold 120,000 shares of Ordinary shares at $30.08 per share (Direct)
  Date: 2026-08-24 | Code: S | equity_swap_involved: 0 | shares_owned_after: 261,683.00 | transaction_form_type: 4 | Footnotes: F6, F4
• Acquired 265,100 shares of Ordinary shares at $11.23 per share (Direct)
  Date: 2026-08-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 382,128.00 | transaction_form_type: 4
• Sold 265,100 shares of Ordinary shares at $30.23 per share (Direct)
  Date: 2026-08-24 | Code: S | equity_swap_involved: 0 | shares_owned_after: 117,028.00 | transaction_form_type: 4 | Footnotes: F5
• Sold 265,000 shares of Employee Stock Option (Right to Buy) at $11.23 per share (Derivative)
  Date: 2026-08-21 | Code: M | Expires: 2030-06-16 | equity_swap_involved: 0 | shares_owned_after: 1,699,149.00 | transaction_form_type: 4 | Footnotes: F7
• Sold 265,100 shares of Employee Stock Option (Right to Buy) at $11.23 per share (Derivative)
  Date: 2026-08-24 | Code: M | Expires: 2030-06-16 | equity_swap_involved: 0 | shares_owned_after: 1,434,049.00 | transaction_form_type: 4 | Footnotes: F7

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.09 to $30.33 inclusive. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to the extent required by law.
• F2: Represents ordinary shares held by The Jesse Singh 2024 Trust, for which the Reporting Person serves as grantor-trustee
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.22 to $30.43 inclusive. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to the extent required by law.
• F4: Represents ordinary shares held by the Jesse Singh 2016 Irrevocable Trust, for which the Reporting Person's spouse serves as trustee
• F5: Represents shares sold through a broker-assisted cashless exercise.
• F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.86 to $30.45 inclusive. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to the extent required by law.
• F7: The options were exercisable as of July 1, 2025, when they were assumed by the issuer in connection with its acquisition of The AZEK Company Inc.